Document Page: First | Prev | Next | All | Image | This Release | Search

File: 123096_sep96_decls1_0098.txt
Page: 0098
Total Pages: 109

Subject: DETECTION OF MEDICAL DEFENSE AGAINST BIOLOGICAL MATERIALS       

Unit: OTSG        

Parent Organization: HSC         

Box  ID: BX003203

Folder Title: DETECTION OF MEDICAL DEFENSE AGAINST BIOLOGICAL MATERIALS                                       

Document Number:          1

Folder Seq  #:         21












                     vaccines, and the limitation on the number of vaccines that can be
                     administered at any one Lime. There are ways in which the efficiency of mass
                     vaccination may be improved.

                            a.  The jet injector will significantly reduce the Lime required to
                            administer vaccines.   IL is not unreasonable to expect an operator to
                            administer 600 Lo 1,000 injections per hour.

                            b. Another possible approach is the use of aerosol immunisation.       This
                            route has been used effectively on a large scale for the immunisation
                            of animals but has not been widely used as a practical substitute for
                            conventional methods in man. This method has one unique and very
                            interesting aspect, in that it is possible that vaccines against
                            diseases normally contracted through the respiratory tract may be more
                            effective when administered by this route. Thus it may be possible to
                            stimulate local immunity in the respiratory tract, as well as systemic
                            immunity provided by the administration of vaccine through the skin.
                            This his Leen shown to occur followin- rer;4r=tory administration of.
                                                                  0      -
                            the influenza vaccine. Although this method appears attractive it has
                            many inherent disadvantages, the principle ones being:
                                                                            I
                                (1)  the quantities of vaccine required are significantly greater
                                than those needed for conventional methods.

rol of individual dosage of the vaccine is extremely
                                difficult.

                                (3)  the equipment is relatively fixed and the vaccinees must be
                                brought to a central point.

                            C. The use of polyvalent combined vaccines offers still another
                            approach toward reducing the burden of vaccine administration. This
                            approach may overcome some of the opposition to a mass immunisation
                            programme by reducing the number of injections.

                     807. The side effects of immunization, although seen infrequently, can
                     produce a significant morbidity; this occurs more often With relatively crude
                     vaccine preparations such as whole cell killed types.    Idiosyncratic reactions
                     are associated with nearly all vaccines but affect a very small number of
                     vaccinees.

                     808. The use of adjuvants and immunopotentiators in animal vaccines to
                     produce enhanced responses to poorly immunogenic vaccines is well
                     documented. Their use in humans is presently limited to enhancing nonspecific
                     immunity in severely compromised patients, by the use of BCG vaccine or other
                     agents. It is i*pected that there will be a greater application of
                     i-unopotenciators in the treatment of infections in the future.

                     809. Passive immunoprophylaxis might also be used in a biological operational
                     situation. The lack of adequate sources of the imunaglabulins, the need for
                     almost immediate diagnosis of the etiological agent, and the limited duration
                     of protection preclude its use, perhaps, except to certain key personnel.




                                                            34

Document Page: First | Prev | Next | All | Image | This Release | Search


Document 109 f:/Week-36/BX003203/DETECTION OF MEDICAL DEFENSE AGAINST BIOLOGICAL MATERIALS/detection of medical defense against biological :1217960927452
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = DETECTION OF MEDICAL DEFENSE AGAINST BIOLOGICAL MATERIALS
Folder Seq # = 21
Subject = DETECTION OF MEDICAL DEFENSE AGAINST BIOLOGICAL
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 17-DEC-1996